Filing Details
- Accession Number:
- 0001209191-16-120984
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-17 18:12:09
- Reporting Period:
- 2016-05-16
- Filing Date:
- 2016-05-17
- Accepted Time:
- 2016-05-17 18:12:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1419600 | Flexion Therapeutics Inc | FLXN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1129890 | W Frederick Driscoll | C/O Flexion Therapeutics, Inc. 10 Mall Road, Suite 301 Burlington MA 01803 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-05-16 | 2,500 | $9.19 | 5,934 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The weighted average purchase price for the transaction reported was $9.18870, and the range of prices were between $8.950 and $9.389. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- Includes 680 shares of Common Stock that were acquired by the Reporting Person on November 20, 2015 pursuant to the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
